Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1

Sara M. Royce, Morad Askari, Kacey G. Marra

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The purpose of this work was to examine the feasibility of a hybrid scaffold in which fibroblast growth factor-1 (FGF-1)-encapsulated microspheres are embedded within a fibrin gel. Such a tissue-engineered scaffold could be incorporated into surgical procedures to promote healing while simultaneously delivering therapeutic agents that promote angiogenesis. Fibrin has been extensively studied as an adhesive in plastic and reconstructive surgery and the enhancement of wound healing with embedded growth factors is desirable. We report the release of a fluorescently-labeled model protein, bovine serum albumin (BSA-FITC), from poly(D,L-lactic-co-glycolic acid) microspheres embedded in the fibrin scaffold. The protein release was found to be significantly delayed as compared to microspheres alone during the initial 24 h of release. Additionally, FGF-1 was examined for efficient incorporation into these scaffolds as a potential mitogen for fibroblasts. The optimal concentration of FGF-1 in the media that enhanced NIH-3T3 fibroblast proliferation over 48 h was determined to be 0.1 μg/ml. The release. of FGF-1 from microspheres embedded in fibrin gels was compared to FGF-1-encapsulated microspheres alone. The release of FGF-1 from the microsphere/scaffolds was delayed as compared to the release of FGF-1 from microspheres alone. This novel hybrid fibrin/microsphere scaffold is a feasible delivery system for growth factors.

Original languageEnglish
Pages (from-to)1327-1336
Number of pages10
JournalJournal of Biomaterials Science, Polymer Edition
Volume15
Issue number10
DOIs
StatePublished - Nov 8 2004
Externally publishedYes

Fingerprint

Fibroblast Growth Factor 1
Fibroblasts
Fibrin
Microspheres
Scaffolds
Polymers
Intercellular Signaling Peptides and Proteins
Reconstructive Surgical Procedures
Gels
Tissue Scaffolds
Proteins
Plastic Surgery
Bovine Serum Albumin
Mitogens
Adhesives
Wound Healing
Scaffolds (biology)
Surgery
Plastics

Keywords

  • Fibrin
  • Fibroblast growth factor
  • Microspheres
  • PLGA

ASJC Scopus subject areas

  • Biophysics
  • Biomaterials

Cite this

Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1. / Royce, Sara M.; Askari, Morad; Marra, Kacey G.

In: Journal of Biomaterials Science, Polymer Edition, Vol. 15, No. 10, 08.11.2004, p. 1327-1336.

Research output: Contribution to journalArticle

@article{7afae57752ce4b078c06637cd579ce8d,
title = "Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1",
abstract = "The purpose of this work was to examine the feasibility of a hybrid scaffold in which fibroblast growth factor-1 (FGF-1)-encapsulated microspheres are embedded within a fibrin gel. Such a tissue-engineered scaffold could be incorporated into surgical procedures to promote healing while simultaneously delivering therapeutic agents that promote angiogenesis. Fibrin has been extensively studied as an adhesive in plastic and reconstructive surgery and the enhancement of wound healing with embedded growth factors is desirable. We report the release of a fluorescently-labeled model protein, bovine serum albumin (BSA-FITC), from poly(D,L-lactic-co-glycolic acid) microspheres embedded in the fibrin scaffold. The protein release was found to be significantly delayed as compared to microspheres alone during the initial 24 h of release. Additionally, FGF-1 was examined for efficient incorporation into these scaffolds as a potential mitogen for fibroblasts. The optimal concentration of FGF-1 in the media that enhanced NIH-3T3 fibroblast proliferation over 48 h was determined to be 0.1 μg/ml. The release. of FGF-1 from microspheres embedded in fibrin gels was compared to FGF-1-encapsulated microspheres alone. The release of FGF-1 from the microsphere/scaffolds was delayed as compared to the release of FGF-1 from microspheres alone. This novel hybrid fibrin/microsphere scaffold is a feasible delivery system for growth factors.",
keywords = "Fibrin, Fibroblast growth factor, Microspheres, PLGA",
author = "Royce, {Sara M.} and Morad Askari and Marra, {Kacey G.}",
year = "2004",
month = "11",
day = "8",
doi = "10.1163/1568562041960016",
language = "English",
volume = "15",
pages = "1327--1336",
journal = "Journal of Biomaterials Science, Polymer Edition",
issn = "0920-5063",
publisher = "Taylor and Francis Ltd.",
number = "10",

}

TY - JOUR

T1 - Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1

AU - Royce, Sara M.

AU - Askari, Morad

AU - Marra, Kacey G.

PY - 2004/11/8

Y1 - 2004/11/8

N2 - The purpose of this work was to examine the feasibility of a hybrid scaffold in which fibroblast growth factor-1 (FGF-1)-encapsulated microspheres are embedded within a fibrin gel. Such a tissue-engineered scaffold could be incorporated into surgical procedures to promote healing while simultaneously delivering therapeutic agents that promote angiogenesis. Fibrin has been extensively studied as an adhesive in plastic and reconstructive surgery and the enhancement of wound healing with embedded growth factors is desirable. We report the release of a fluorescently-labeled model protein, bovine serum albumin (BSA-FITC), from poly(D,L-lactic-co-glycolic acid) microspheres embedded in the fibrin scaffold. The protein release was found to be significantly delayed as compared to microspheres alone during the initial 24 h of release. Additionally, FGF-1 was examined for efficient incorporation into these scaffolds as a potential mitogen for fibroblasts. The optimal concentration of FGF-1 in the media that enhanced NIH-3T3 fibroblast proliferation over 48 h was determined to be 0.1 μg/ml. The release. of FGF-1 from microspheres embedded in fibrin gels was compared to FGF-1-encapsulated microspheres alone. The release of FGF-1 from the microsphere/scaffolds was delayed as compared to the release of FGF-1 from microspheres alone. This novel hybrid fibrin/microsphere scaffold is a feasible delivery system for growth factors.

AB - The purpose of this work was to examine the feasibility of a hybrid scaffold in which fibroblast growth factor-1 (FGF-1)-encapsulated microspheres are embedded within a fibrin gel. Such a tissue-engineered scaffold could be incorporated into surgical procedures to promote healing while simultaneously delivering therapeutic agents that promote angiogenesis. Fibrin has been extensively studied as an adhesive in plastic and reconstructive surgery and the enhancement of wound healing with embedded growth factors is desirable. We report the release of a fluorescently-labeled model protein, bovine serum albumin (BSA-FITC), from poly(D,L-lactic-co-glycolic acid) microspheres embedded in the fibrin scaffold. The protein release was found to be significantly delayed as compared to microspheres alone during the initial 24 h of release. Additionally, FGF-1 was examined for efficient incorporation into these scaffolds as a potential mitogen for fibroblasts. The optimal concentration of FGF-1 in the media that enhanced NIH-3T3 fibroblast proliferation over 48 h was determined to be 0.1 μg/ml. The release. of FGF-1 from microspheres embedded in fibrin gels was compared to FGF-1-encapsulated microspheres alone. The release of FGF-1 from the microsphere/scaffolds was delayed as compared to the release of FGF-1 from microspheres alone. This novel hybrid fibrin/microsphere scaffold is a feasible delivery system for growth factors.

KW - Fibrin

KW - Fibroblast growth factor

KW - Microspheres

KW - PLGA

UR - http://www.scopus.com/inward/record.url?scp=7044260759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044260759&partnerID=8YFLogxK

U2 - 10.1163/1568562041960016

DO - 10.1163/1568562041960016

M3 - Article

VL - 15

SP - 1327

EP - 1336

JO - Journal of Biomaterials Science, Polymer Edition

JF - Journal of Biomaterials Science, Polymer Edition

SN - 0920-5063

IS - 10

ER -